Are psychedelics safe to use?
According to the head of a drug research organisation, the use of psychedelic drugs is no more dangerous than cycling, playing football or smoking cigarettes.
He says that 30 million adults in the US have tried psychedelics and there is no evidence that they do any harm, but certain drugs could be useful in reducing dependence on other, more harmful substances. This is contrary to human rights, and compared to alcohol and other controlled substances, psychedelic drugs are much less harmful to human health than other drugs, “says Dr. John Johansen, director of the Psychedelics Recovery Centre at the University of California, San Diego. These kinds of narratives are common among the people who participate in our recreational groups, as psychedelic consumption is considered a relapse and can push them to the substances that have caused them the most problems, such as alcohol.
One fear associated with this, says Negrin, is to replace one substance with another by getting medication, only to become addicted to micro-dosing psychedelics. Like most psychedelic mushrooms, they cannot really be used to numb or escape problems with other substances, but they are considered addictive, even though classical psychedelic magic mushrooms do not encourage compulsive use of opioids, meth, or alcohol.
People who have mental or emotional problems may simply be trying to change their state of mind, but since hallucinogenic drugs are not currently approved for such use, they have not been tested to see if they could have any negative effects on the brain, such as depression, anxiety or other mental health problems. According to research published in 2017, anecdotal reports and small studies suggest ayahuasca could be an effective treatment for a range of mental and emotional disorders, from depression to anxiety and depression. However, according to the National Institute of Mental Health, there is still no large-scale research to verify its effectiveness.
Some research suggests that hallucinogens work by temporarily disrupting the brain’s ability to process information such as thoughts, memories, emotions and emotions.
The DEA’s move was likely influenced by a study in the Journal of Psychopharmacology that found there was no evidence of harmful effects of using LSD or psilocybin in people under 18. If successful, the study raises questions about the safety and efficacy of psychedelic drugs for adults and children. Although individual adverse events occurred and dependence on certain psychedelics can be devastating, another study of 190,000 respondents found that people who used LSD and p-silocybins had no significant impact on their mental health or behavior, according to the Drug Enforcement Administration.
One of six LSD studies conducted on 500 people in the 1960 “s found that even one dose of LSD caused an increase in anxiety and depression in a control group that reached only 38%, according to the Drug Enforcement Administration.
Psychedelic therapy has also been linked to other mental health problems, including addiction to social media. Other studies have highlighted how MDMA - assisted psychotherapy - could be used to help people suffering from various forms of PTSD. A 2012 study published in the Journal of Psychopharmacology highlights how LSD and psilocybin could potentially be used to treat alcohol addiction.
Similar to ayahuasca, brain scans have shown that psilocybin can suppress activity in the brain’s standard mode network, and people who stumble across shrooms report experiencing high levels of happiness and belonging to the world. Recent research could prove the potential of p-silocybines for the treatment of depression and other mental illnesses. Psilocin has thrilled researchers because it has shown time and again that it can help people with depression.
The Lancet found that high doses of the fungus reduced depressive symptoms in treatment-resistant patients. These psychological benefits have led researchers to believe that psychedelics could be an effective therapeutic treatment.
Indeed, many studies have found that, one way or another, all four drugs have the potential to treat a wide range of mental disorders, including depression, anxiety, schizophrenia, and bipolar disorder.
At the very least, recent research suggests that ayahuasca, DMT, MDMA, and psilocybin mushrooms have the potential to transform the way doctors treat mental illness, as well as those that are resistant. Microdosing means taking a small dose of one of the psychedelic drugs such as MDMA or diazepam or even a tiny amount of a psychedelic drug such as silica (a form of dioxin) or pilocaine (the psychoactive ingredient in lager). With an open mind, so this theory, people under the influence of psychedelics can tackle their mental illness without shame or fear.
Microdosing with certain psychedelics is said to induce physical and mental stimulation, improve mood, promote creative thinking, and induce relaxation. Recent studies support the idea that hallucinogenic drugs such as ayahuasca, DMT, MDMA, psilocybin mushrooms, or even diazepam can be used to treat depression, anxiety, post-traumatic stress disorder (PTSD), and other mental illnesses.